Literature DB >> 18039114

Regulation of lung inflammation in the model of IgG immune-complex injury.

Hongwei Gao1, Thomas Neff, Peter A Ward.   

Abstract

Modern techniques of cell and molecular biology have rapidly uncovered the mechanisms underlying inflammatory injury of the lung. This expanding knowledge (which includes an understanding of complement, cell surface receptors, cytokines and chemokines, transcription factors, oxidants, proteinases, and endogenous inhibitors, as well as the role of leukocyte adhesion-promoting molecules) has provided new insights into the inflammatory system in general, as well as in the context of lung injury. In this review, we summarize recent progress in understanding the regulation of lung inflammation by using immunoglobulin G (IgG) immune complex-induced lung injury as a model. These studies have provided information on the role of various inflammatory mediators and their sequence of engagement. Insights into potential interventional approaches for the suppression of inflammatory processes in humans have emerged from those studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 18039114     DOI: 10.1146/annurev.pathol.1.110304.100155

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  31 in total

1.  C5a-regulated CCAAT/enhancer-binding proteins β and δ are essential in Fcγ receptor-mediated inflammatory cytokine and chemokine production in macrophages.

Authors:  Chunguang Yan; Mei Zhu; Jennifer Staiger; Peter F Johnson; Hongwei Gao
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

Review 2.  Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?

Authors:  Charles N Serhan
Journal:  Am J Pathol       Date:  2010-09-02       Impact factor: 4.307

3.  MicroRNA-127 inhibits lung inflammation by targeting IgG Fcγ receptor I.

Authors:  Ting Xie; Jiurong Liang; Ningshan Liu; Qingguo Wang; Yuhang Li; Paul W Noble; Dianhua Jiang
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

4.  Contributing factors in the development of acute lung injury in a murine double hit model.

Authors:  Philipp Störmann; Nils Becker; Leander Künnemeyer; Sebastian Wutzler; Jan Tilmann Vollrath; Thomas Lustenberger; Frank Hildebrand; Ingo Marzi; Borna Relja
Journal:  Eur J Trauma Emerg Surg       Date:  2019-04-01       Impact factor: 3.693

5.  Anti-inflammatory effects of β2 adrenergic receptor agonists in experimental acute lung injury.

Authors:  Markus Bosmann; Jamison J Grailer; Ketong Zhu; Michael A Matthay; J Vidya Sarma; Firas S Zetoune; Peter A Ward
Journal:  FASEB J       Date:  2012-02-07       Impact factor: 5.191

6.  Extracellular histones are essential effectors of C5aR- and C5L2-mediated tissue damage and inflammation in acute lung injury.

Authors:  Markus Bosmann; Jamison J Grailer; Robert Ruemmler; Norman F Russkamp; Firas S Zetoune; J Vidya Sarma; Theodore J Standiford; Peter A Ward
Journal:  FASEB J       Date:  2013-08-27       Impact factor: 5.191

Review 7.  B-lymphocyte lineage cells and the respiratory system.

Authors:  Atsushi Kato; Kathryn E Hulse; Bruce K Tan; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2013-04       Impact factor: 10.793

Review 8.  Alveolar epithelial and endothelial cell apoptosis in emphysema: what we know and what we need to know.

Authors:  Mathieu C Morissette; Julie Parent; Julie Milot
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15

9.  CD11c+ alveolar macrophages are a source of IL-23 during lipopolysaccharide-induced acute lung injury.

Authors:  Markus Bosmann; Jamison J Grailer; Norman F Russkamp; Robert Ruemmler; Firas S Zetoune; J Vidya Sarma; Peter A Ward
Journal:  Shock       Date:  2013-05       Impact factor: 3.454

10.  Does activation of the FcgammaRIIa play a role in the pathogenesis of the acute lung injury/acute respiratory distress syndrome?

Authors:  Rafal Fudala; Agnieszka Krupa; Dorota Stankowska; Timothy C Allen; Anna K Kurdowska
Journal:  Clin Sci (Lond)       Date:  2010-01-26       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.